IP Library Granted Patent US 11,464,829
Granted Patent B2
US 11,464,829 · App. 16/514,662 · Granted Oct 11, 2022

Platelet activation and growth factor release using electric pulses

Inventors: Vasile Bogdan Neculaes (Niskayuna, NY); Andrew Soliz Torres (Niskayuna, NY); Antonio Caiafa (Albany, NY); Brian Dun-Lan Lee (Rexford, NY); Allen Lawrence Garner (West Lafayette, NY)
Assignee: GENERAL ELECTRIC COMPANY
A61K38/1858A61K35/19C12N13/00G01N33/48707G01N33/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,829
App. No.
16/514,662
Granted
Oct 11, 2022
Kind
B2
Abstract

Methods and systems for releasing growth factors are disclosed. In certain embodiments, a blood sample is exposed to a sequence of one or more electric pulses to trigger release of a growth factor in the sample. In certain embodiments, the growth factor release is not accompanied by clotting within the blood sample.

Claims (11)

1. A method for releasing growth factors, comprising:

exposing a blood sample to a sequence of one or more electric pulses to trigger release of the growth factors in the blood sample, wherein the one or more electric pulses have an electric field strength between 0.1 kV/cm and 350 kV/cm and pulse durations between 1 nanosecond and 100 microsecond, wherein calcium chloride (CaCl2) is not added to the blood sample prior to or during the exposure of the blood sample to the sequence of one or more electric pulses, whereby the growth factor release is not accompanied by clotting within the blood sample; and

collecting the released growth factors.

2. The method of claim 1 , wherein the blood sample was acquired from a patient.

3. The method of claim 1 , wherein the growth factors comprise platelet derived growth factors.

4. The method of claim 1 , wherein the blood sample comprises a whole blood sample or a platelet rich plasma.

5. The method of claim 1 , wherein a shape of the one or more electrical pulses is defined by user input or a stored protocol setting.

6. The method of claim 1 , further comprising:

exposing the blood sample to a sensing signal having an electric field strength below the electric field strength of the one or more electric pulses prior to exposing the blood sample to the sequence of one or more electric pulses that trigger release of the growth factors in the blood sample.

7. The method of claim 6 , wherein the sensing signal is used to estimate a conductivity or a permittivity of the blood sample.

8. The method of claim 1 , wherein the collected growth factors are used for wound healing at a site of an injury.

Assignments (4)
QUITCLAIM ASSIGNMENT Recorded Sep 18, 2025
From: EDISON INNOVATIONS LLC
To: BLUE RIDGE INNOVATIONS, LLC
Reel/Frame 072938/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2025
From: GENERAL ELECTRIC COMPANY
To: GE INTELLECTUAL PROPERTY LICENSING, LLC
Reel/Frame 070636/0815 →
CHANGE OF NAME Recorded Mar 26, 2025
From: GE INTELLECTUAL PROPERTY LICENSING, LLC
To: DOLBY INTELLECTUAL PROPERTY LICENSING, LLC
Reel/Frame 070643/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2025
From: DOLBY INTELLECTUAL PROPERTY LICENSING, LLC
To: EDISON INNOVATIONS, LLC
Reel/Frame 070293/0273 →
Continuity (3)
Continuation 15252032 · Aug 30, 2016
Continuation 14157819 · Jan 17, 2014
Related Publication 20190336578A1 · Nov 7, 2019